Brief: Corline Biomedical Q2 Pretax Loss Narrows To SEK 2.2 Mln
Aug 25 (Reuters) - Corline Biomedical AB CLBIO.ST :
* Q2 NET SALES SEK 1.3 MILLION VERSUS SEK 0.6 MILLION YEAR
AGO
* Q2 PRETAX LOSS SEK 2.2 MILLION VERSUS LOSS SEK 2.6
MILLION YEAR
AGO
Source text for Eikon: ID:nGNE11mnX7
Further company coverage: CLBIO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Corline Biomedical AB
See all newsBrief: Corline Biomedical Expectes Positive EBITDA In 2027
Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
Brief: Corline Biomedical Q2 Net Sales Amount To SEK 4.7 Million
Brief: Corline Biomedical Partner Kardium Receives Approval For Globe Pulsed Field System In Canada
Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln